Biotech Growth Investors & VC Firms
708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Brandon Capital Partners
MelbourneSeed–Growth
1 person
Nan Fung Life Sciences
Hong KongSeed–Growth
1 person
Capricornio Capital
Growth–Late Stage$1M – $10M
Harriet Ventures
Series A–Growth$500K – $50M
Quam Venture Capital
Pre-Seed–Growth$500K – $10M
CBC Group
SingaporeSeed–Late Stage
2 people
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Entrepreneurs Fund
LondonSeries A–Growth
2 people
PONTIS
ViennaSeed–Growth
2 people
Ippon
GenevaSeries A–Growth
1 person
Woodford Investment Management
OxfordSeries A–Growth
EISAI CO.,LTD
TokyoSeed–Growth
1 person
RecapHealth Ventures
VancouverSeed–Late Stage
1 person
Shanghai STVC Group
ShanghaiSeed–Growth
1 person
Archimede Ventures
IstanbulGrowth
1 person
HSBC Innovation Ventures
LondonSeed–Growth
1 person
SIVENT d.d.
LjubljanaGrowth
1 person
Inventure Capital
AarhusSeed–Growth
Providence Investment Company Limited
GermanySeed–Growth
Care Capital
PrincetonSeed–Growth
Lake Bleu Capital
Hong KongSeed–Growth
Avlar BioVentures
MadingleySeries A–Growth
Hong Kong X Technology Fund
Hong KongSeed–Growth
AIP Private Equity
TorontoGrowth
Related lists
Growth Investors & VC Firms (4263)Biotech Investors & VC Firms (2475)Growth Investors & VC Firms in North America (2121)Biotech Seed Investors & VC Firms (2020)Growth Investors & VC Firms in United States (1837)Growth Investors & VC Firms in Europe (1633)Biotech Series A Investors & VC Firms (1626)Biotech Investors & VC Firms in North America (1594)Biotech Investors & VC Firms in United States (1445)Growth Investors & VC Firms in Global (1377)
Data sourced from public filings and firms' own websites — see our methodology.





